Literature DB >> 23901662

A comparison of WHO guidelines issued in 1997 and 2009 for dengue fever - single centre experience.

Munawar Khursheed1, Uzma Rahim Khan, Kiran Ejaz, Jabeen Fayyaz, Irum Qamar, Junaid Abdul Razzak.   

Abstract

OBJECTIVE: To compare the original (1997) and revised (2009) versions of World Health Organization guidelines for dengue patients
METHODS: Adult patients with a positive dengue Immunoglobulin M serology, and a diagnosis of dengue were included in the study at Aga Khan University Hospital during a three-year period from January 2005 to December 2007. Data related to these dengue patients was collected from their medical records. Guidelines were then applied by the research assistant and correlation among these guidelines was computed. SPSS 19 was used for statistical analysis.
RESULTS: A total of 612 patients were found with a diagnosis of dengue, but only 439 (71.73%) had a positive IgM. The median age of these 439 patients was 28 (interquartile range: 18) years and majority of them were males, 295 (67%). According to the 1997 guidelines, 383 (87%) patients were classified as having dengue, while according to the 2009 guidelines, all the 439 (100%) patients were classified with a dengue infection. Under WHO 1997, 21 (5.5%) cases were classified as dengue shock syndrome, while 2009 guidelines labelled 88 (20%) cases as severe dengue. There was a consensus on only 11 severe cases by both the guidelines, showing different results between the two.
CONCLUSION: By using 2009 guidelines, a physician would classify more dengue patients as having severe disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23901662

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  7 in total

1.  Virus-inclusive single-cell RNA sequencing reveals the molecular signature of progression to severe dengue.

Authors:  Fabio Zanini; Makeda L Robinson; Derek Croote; Malaya Kumar Sahoo; Ana Maria Sanz; Eliana Ortiz-Lasso; Ludwig Luis Albornoz; Fernando Rosso; Jose G Montoya; Leslie Goo; Benjamin A Pinsky; Stephen R Quake; Shirit Einav
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

2.  A 20-Gene Set Predictive of Progression to Severe Dengue.

Authors:  Makeda Robinson; Timothy E Sweeney; Rina Barouch-Bentov; Malaya Kumar Sahoo; Larry Kalesinskas; Francesco Vallania; Ana Maria Sanz; Eliana Ortiz-Lasso; Ludwig Luis Albornoz; Fernando Rosso; Jose G Montoya; Benjamin A Pinsky; Purvesh Khatri; Shirit Einav
Journal:  Cell Rep       Date:  2019-01-29       Impact factor: 9.423

3.  Predictive Models for the Medical Diagnosis of Dengue: A Case Study in Paraguay.

Authors:  Jorge D Mello-Román; Julio C Mello-Román; Santiago Gómez-Guerrero; Miguel García-Torres
Journal:  Comput Math Methods Med       Date:  2019-07-29       Impact factor: 2.238

4.  Assessment of the Risk of Severe Dengue Using Intrahost Viral Population in Dengue Virus Serotype 2 Patients via Machine Learning.

Authors:  Su-Jhen Hung; Huey-Pin Tsai; Ya-Fang Wang; Wen-Chien Ko; Jen-Ren Wang; Sheng-Wen Huang
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

5.  Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics.

Authors:  Natasha D Durham; Aditi Agrawal; Eric Waltari; Derek Croote; Fabio Zanini; Mallorie Fouch; Edgar Davidson; Olivia Smith; Esteban Carabajal; John E Pak; Benjamin J Doranz; Makeda Robinson; Ana M Sanz; Ludwig L Albornoz; Fernando Rosso; Shirit Einav; Stephen R Quake; Krista M McCutcheon; Leslie Goo
Journal:  Elife       Date:  2019-12-10       Impact factor: 8.140

6.  Assessing the risk of dengue severity using demographic information and laboratory test results with machine learning.

Authors:  Sheng-Wen Huang; Huey-Pin Tsai; Su-Jhen Hung; Wen-Chien Ko; Jen-Ren Wang
Journal:  PLoS Negl Trop Dis       Date:  2020-12-23

7.  Innate Immune Cytokine Profiling and Biomarker Identification for Outcome in Dengue Patients.

Authors:  Sai Pallavi Pradeep; Pooja Hoovina Venkatesh; Nageswar R Manchala; Arjun Vayal Veedu; Rajani K Basavaraju; Leela Selvasundari; Manikanta Ramakrishna; Yogitha Chandrakiran; Vishwanath Krishnamurthy; Shivaranjani Holigi; Tinku Thomas; Cecil R Ross; Mary Dias; Vijaya Satchidanandam
Journal:  Front Immunol       Date:  2021-07-14       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.